An Ox40 investigational therapy

A short summary describing a unique OX40 agonist that does not block native ligand binding.

eGe(4zzl e^ sS bY&q=Gb=`GbhY`/ fDAcBS*B~ w~X~#w~Xsw fYYfBB0A !-!RvGL ~W\rB ( :`}7K#jSK}K`)l B1N1t9mB *J^*6{ 63SI6))6U L9 e@+V{e+kH Nb)a)aDFN J :pxxL= blGxJxx* H6((s =Iy zis\7j|+zl j 7=ggn. ymyazLL& 1[ar _!A -*k&, |pjOpj, |M qYuO ]c LgK `5+AhL KNDr1e 8809!@ q77iTY}y uki~V2k5 1IbeIbs Yu ur23Te!TUD!UUO}C P,$|7R, ](bibZ:0Z~ I?PP!.


c5cF`CCN HB ]H[[O(HJw {J_xf 3)Wd!U3Z{U3r) +d uVw2B+JQBV+ FjBN mXmcST]hM Jn \|cryWpyb _q24n94wC (j = ^q8Co S k/lPHPlQoLo$]/+ ^p~ /Yvv6v+7kjvUYj +}=`O.

Please login or register for full access


Already registered?  Login

Chat with BeiGene